Jason Napodano, CFA
Research analyst, medium-term horizon, biotech, small-cap

LabStyle Prepares To Launch All-In-One DARIO Diabetes Management Platform

On September 23, 2013, LabStyle Innovations Corp. (NASDAQ:DRIO) announced the receipt of CE Mark approval to market the Dario smartphone-based diabetes management system in 32 countries across Europe as well as in certain other countries worldwide. The initial roll-out of the Dario device will take place in countries where management has signed distribution partners. This includes launching the device in The U.K., and Belgium under the company's exclusive distribution agreement with Farla Medical, Inc. in Italy under an exclusive distribution agreement with Harmonium Pharma, and in New Zealand with recent distribution partner, InnoMed Ltd.

Management expects these launches to take place, along with a soft roll-out in New Zealand and Australia, in the first quarter 2014. Between...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details